168 related articles for article (PubMed ID: 22264311)
1. Ocular medicines in children: the regulatory situation related to clinical research.
Fortinguerra F; Clavenna A; Bonati M
BMC Pediatr; 2012 Jan; 12():8. PubMed ID: 22264311
[TBL] [Abstract][Full Text] [Related]
2. Pain management in the paediatric population: the regulatory situation in Europe.
Fortinguerra F; Maschi S; Clavenna A; Bonati M
Arch Dis Child; 2010 Sep; 95(9):749-53. PubMed ID: 20584850
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
Hwang TJ; Tomasi PA; Bourgeois FT
PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
[TBL] [Abstract][Full Text] [Related]
5. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
6. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
7. Effect of the pediatric exclusivity provision on children's access to medicines.
Grieve J; Tordoff J; Reith D; Norris P
Br J Clin Pharmacol; 2005 Jun; 59(6):730-5. PubMed ID: 15948940
[TBL] [Abstract][Full Text] [Related]
8. Practical use and prescription of ocular medications in children and infants.
Webber AL; Sharwood P
Clin Exp Optom; 2021 Apr; 104(3):385-395. PubMed ID: 33689620
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents.
Cooper TE; Heathcote LC; Anderson B; Grégoire MC; Ljungman G; Eccleston C
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012563. PubMed ID: 28737843
[TBL] [Abstract][Full Text] [Related]
10. Over-the-counter medications for acute cough in children and adults in ambulatory settings.
Schroeder K; Fahey T
Cochrane Database Syst Rev; 2004 Oct; (4):CD001831. PubMed ID: 15495019
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Mitry D; Bunce C; Charteris D
Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
13. Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.
Dick A; Keady S; Mohamed F; Brayley S; Thomson M; Lloyd BW; Heuschkel R; Afzal NA
Aliment Pharmacol Ther; 2003 Feb; 17(4):571-5. PubMed ID: 12622766
[TBL] [Abstract][Full Text] [Related]
14. The evidence-based choice for antipsychotics in children and adolescents should be guaranteed.
Putignano D; Clavenna A; Reale L; Bonati M
Eur J Clin Pharmacol; 2019 Jun; 75(6):769-776. PubMed ID: 30729258
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
[TBL] [Abstract][Full Text] [Related]
16. Oral medicines for children in the European paediatric investigation plans.
van Riet-Nales DA; Römkens EG; Saint-Raymond A; Kozarewicz P; Schobben AF; Egberts TC; Rademaker CM
PLoS One; 2014; 9(6):e98348. PubMed ID: 24897509
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of ocular surgery.
Noecker RJ; Golightly SF
J Ophthalmic Nurs Technol; 1999; 18(3):101-8; quiz 124-7. PubMed ID: 10633657
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trials and licensing of monoclonal antibodies and biological medicines for cancer treatment in Brazil].
Silva CF; Silva MV; Osorio-de-Castro CG
Rev Panam Salud Publica; 2016 Mar; 39(3):149-156. PubMed ID: 27754528
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.
Dretzke J; Edlin R; Round J; Connock M; Hulme C; Czeczot J; Fry-Smith A; McCabe C; Meads C
Health Technol Assess; 2011 Feb; 15(6):1-244. PubMed ID: 21291629
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
